Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Merck KGaA Buys Interest In Israeli Start-up QLight Nanotech - Quick Facts

Merck KGaA (MKGAY.PK) said it is acquiring an interest in Israeli start-up company QLight Nanotech. QLight Nanotech is a spin-off subsidiary of Yissum, the technology transfer company of the Hebrew University of Jerusalem.

With this investment Merck will hold an equity stake in the Israel start-up company. Further financial details were not disclosed.

Merck's investment would help the company to accelerate the development of quantum dot-based technology for new applications. Upon the achievement of R&D milestones, Merck could further raise its stake in Qlight Nanotech, as well as develop and commercialize the new products in its Performance Materials division.

The deal is expected to close in the second quarter of 2012.

Click here to receive FREE breaking news email alerts for Merck KGaA and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Beverages giant Coca-Cola Co. reported Tuesday a profit for the third quarter that decreased 14 percent from last year, despite higher worldwide volumes, reflecting a revenue drop. Adjusted earnings per share matched analysts' expectations, even as quarterly revenues missed their estimates. Following the announcement, the company's shares are trading more than five percent lower in early deals. Apple Inc. said Monday that its fourth quarter profit rose 13% from last year, driven by strong sales of its iPhones and Mac computers. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly sales. At the same time, the company gave an upbeat revenue forecast for the current quarter, which includes the all important holiday season. Programmable chipmaker Xilinx Inc. (XLNX) said Thursday after the markets closed that its second quarter profit rose 21% from last year, helped by higher revenue and better cost control. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue....
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.